Patent ID: 11911407
Assignee: UNIVERSITY COLLEGE, DUBLIN, NATIONAL UNIVERSITY OF IRELEAND, DUBLIN
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  G | IPC A  C  G

Claim 5:
6. A method of preventing a cardiomyopathy selected from the group consisting of hypertrophic cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and endomyocardial fibrosis comprising the step of administering to a patient in need thereof a pharmaceutical composition comprising a hypomethylating agent and a pharmaceutically acceptable excipient, wherein the hypomethylating agent comprises 5-Azacytidine or 5-Aza-2′-Deoxycytidine, or a pharmaceutically acceptable salt of each thereof, with the proviso that the patient is not suffering from a cancer or a haematological disease.